RxDoctor Payments DataLook up a doctor →

OMIDRIA: payments to doctors

Payments that named OMIDRIA as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$1.3M
Providers
5,201
Transactions
11,420
Average per transaction
$112

The per-transaction average — $112 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 5,201 providers the average total is $245, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Omeros Corporation$863,18067.8%
Rayner Intraocular Lenses Limited$410,61132.2%
← All drugs & devices